ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176323 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176323; 2) Community: the network communities that were significantly associated with the response to NSC 176323; 3) Molecule: the relationships between components within communities and NSC 176323; 4) MDR: the compounds that were significantly associated with the NSC 176323.

NSC Compound Enrichment Correlation
NSC 676591 Null 0.024108502230778 0.20907551
NSC 678914 4-Acridinecarboxamide, N-[2-(dimethylamino)ethyl]- 1-methoxy-, dihydrochloride 0.024108502230778 0.45369212
NSC 713018 Null 0.024108502230778 0.18180788
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.024108502230778 0.092235385
NSC 758664 Sirolimus [USAN] 0.024108502230778 0.085526343
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0241085022307781 0.017642769
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0241085022307781 0.32875484
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0241085022307781 0.49083199
NSC 23925 Null 0.0247979034812107 0.11463203
NSC 689540 Null 0.024797903481211 0.083322513
Total:54  Current:28    [First] [Prev] [Next] [Last]